Clinical Trial Detail

NCT ID NCT04294628
Title Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Trastuzumab deruxtecan

Age Groups: adult senior

Additional content available in CKB BOOST